APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biologics Development Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Biologics Development Service Market Analysis and Forecast 2026-2032

2 May 2026249 pages

Choose your research edition.

Industry ResearchBiologics Development Service Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Biologics Development Service Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Biologics Development Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biologics Development Service Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Biologics Development Service Market Analysis and Forecast 2026-2032249 pages · $4,950 USD

Market perspective

The global Biologics Development Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Biologics Development Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Biologics Development Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Biologics Development Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Biologics Development Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Biologics Development Service include Meso Scale Discovery, Patheon, Immunologix, GenScript, Promega, Recibiopharm, Alcami Biologics, Leadgene Biomedical and Samsung Biologics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Biologics Development Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Biologics Development Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Biologics Development Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biologics Development Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biologics Development Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Biologics Development Service revenue, projected growth trends, production technology, application and end-user industry.

Biologics Development Service Segment by Company

Meso Scale Discovery

Patheon

Immunologix

GenScript

Promega

Recibiopharm

Alcami Biologics

Leadgene Biomedical

Samsung Biologics

Lonza

ImmunoGen

Seattle Genetics

Roche

Takeda

Biologics Development Service Segment by Type

Vaccine

Blood and Blood Components

Tissue and Recombinant Therapeutic Proteins

Others

Biologics Development Service Segment by Application

Tumor Treatment

Chronic Disease Treatment

Enzyme and Hormone Deficiencies

Others

Biologics Development Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologics Development Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biologics Development Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologics Development Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Biologics Development Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Biologics Development Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biologics Development Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biologics Development Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Vaccine Major Player Table 3. Blood and Blood Components Major Player Table 4. Tissue and Recombinant Therapeutic Proteins Major Player Table 5. Others Major Player Table 6. Global Biologics Development Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Tumor Treatment Major Player Table 8. Chronic Disease Treatment Major Player Table 9. Enzyme and Hormone Deficiencies Major Player Table 10. Others Major Player Table 11. Biologics Development Service Industry Trends Table 12. Biologics Development Service Industry Drivers Table 13. Biologics Development Service Industry Opportunities and Challenges Table 14. Biologics Development Service Industry Restraints Table 15. Global Biologics Development Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Biologics Development Service Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Biologics Development Service Market Share by Region (2021-2026) Table 18. Global Biologics Development Service Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Biologics Development Service Market Share by Region (2027-2032) Table 20. Global Biologics Development Service Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Biologics Development Service Revenue Market Share by Players (2021-2026) Table 22. Global Biologics Development Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Biologics Development Service Key Players Headquarters & Area Served Table 24. Global Biologics Development Service Players, Product Type & Application Table 25. Global Biologics Development Service Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Biologics Development Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Biologics Development Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Biologics Development Service Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Biologics Development Service Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Biologics Development Service Revenue Market Share by Type (2021-2026) Table 32. Global Biologics Development Service Revenue Market Share by Type (2027-2032) Table 33. Global Biologics Development Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Biologics Development Service Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Biologics Development Service Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Biologics Development Service Revenue Market Share by Application (2021-2026) Table 37. Global Biologics Development Service Revenue Market Share by Application (2027-2032) Table 38. Meso Scale Discovery Company Information Table 39. Meso Scale Discovery Business Overview Table 40. Meso Scale Discovery Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Meso Scale Discovery Biologics Development Service Product Portfolio Table 42. Meso Scale Discovery Recent Development Table 43. Patheon Company Information Table 44. Patheon Business Overview Table 45. Patheon Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Patheon Biologics Development Service Product Portfolio Table 47. Patheon Recent Development Table 48. Immunologix Company Information Table 49. Immunologix Business Overview Table 50. Immunologix Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Immunologix Biologics Development Service Product Portfolio Table 52. Immunologix Recent Development Table 53. GenScript Company Information Table 54. GenScript Business Overview Table 55. GenScript Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. GenScript Biologics Development Service Product Portfolio Table 57. GenScript Recent Development Table 58. Promega Company Information Table 59. Promega Business Overview Table 60. Promega Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Promega Biologics Development Service Product Portfolio Table 62. Promega Recent Development Table 63. Recibiopharm Company Information Table 64. Recibiopharm Business Overview Table 65. Recibiopharm Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Recibiopharm Biologics Development Service Product Portfolio Table 67. Recibiopharm Recent Development Table 68. Alcami Biologics Company Information Table 69. Alcami Biologics Business Overview Table 70. Alcami Biologics Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Alcami Biologics Biologics Development Service Product Portfolio Table 72. Alcami Biologics Recent Development Table 73. Leadgene Biomedical Company Information Table 74. Leadgene Biomedical Business Overview Table 75. Leadgene Biomedical Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Leadgene Biomedical Biologics Development Service Product Portfolio Table 77. Leadgene Biomedical Recent Development Table 78. Samsung Biologics Company Information Table 79. Samsung Biologics Business Overview Table 80. Samsung Biologics Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Samsung Biologics Biologics Development Service Product Portfolio Table 82. Samsung Biologics Recent Development Table 83. Lonza Company Information Table 84. Lonza Business Overview Table 85. Lonza Biologics Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Lonza Biologics Development Service Product Portfolio Table 87. Lonza Recent Development Table 88. ImmunoGen Company Information Table 89. ImmunoGen Business Overview Table 90. ImmunoGen Biologics Development Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. ImmunoGen Biologics Development Service Product Portfolio Table 92. ImmunoGen Recent Development Table 93. Seattle Genetics Company Information Table 94. Seattle Genetics Business Overview Table 95. Seattle Genetics Biologics Development Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Seattle Genetics Biologics Development Service Product Portfolio Table 97. Seattle Genetics Recent Development Table 98. Roche Company Information Table 99. Roche Business Overview Table 100. Roche Biologics Development Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Roche Biologics Development Service Product Portfolio Table 102. Roche Recent Development Table 103. Takeda Company Information Table 104. Takeda Business Overview Table 105. Takeda Biologics Development Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Takeda Biologics Development Service Product Portfolio Table 107. Takeda Recent Development Table 108. North America Biologics Development Service Revenue by Type (2021-2026) & (US$ Million) Table 109. North America Biologics Development Service Revenue by Type (2027-2032) & (US$ Million) Table 110. North America Biologics Development Service Revenue by Application (2021-2026) & (US$ Million) Table 111. North America Biologics Development Service Revenue by Application (2027-2032) & (US$ Million) Table 112. North America Biologics Development Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. North America Biologics Development Service Revenue by Country (2021-2026) & (US$ Million) Table 114. North America Biologics Development Service Revenue by Country (US$ Million) & (2027-2032) Table 115. Europe Biologics Development Service Revenue by Type (2021-2026) & (US$ Million) Table 116. Europe Biologics Development Service Revenue by Type (2027-2032) & (US$ Million) Table 117. Europe Biologics Development Service Revenue by Application (2021-2026) & (US$ Million) Table 118. Europe Biologics Development Service Revenue by Application (2027-2032) & (US$ Million) Table 119. Europe Biologics Development Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Europe Biologics Development Service Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Biologics Development Service Revenue by Country (US$ Million) & (2027-2032) Table 122. China Biologics Development Service Revenue by Type (2021-2026) & (US$ Million) Table 123. China Biologics Development Service Revenue by Type (2027-2032) & (US$ Million) Table 124. China Biologics Development Service Revenue by Application (2021-2026) & (US$ Million) Table 125. China Biologics Development Service Revenue by Application (2027-2032) & (US$ Million) Table 126. Asia Biologics Development Service Revenue by Type (2021-2026) & (US$ Million) Table 127. Asia Biologics Development Service Revenue by Type (2027-2032) & (US$ Million) Table 128. Asia Biologics Development Service Revenue by Application (2021-2026) & (US$ Million) Table 129. Asia Biologics Development Service Revenue by Application (2027-2032) & (US$ Million) Table 130. Asia Biologics Development Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 131. Asia Biologics Development Service Revenue by Region (US$ Million) & (2021-2026) Table 132. Asia Biologics Development Service Revenue by Region (US$ Million) & (2027-2032) Table 133. SAMEA Biologics Development Service Revenue by Type (2021-2026) & (US$ Million) Table 134. SAMEA Biologics Development Service Revenue by Type (2027-2032) & (US$ Million) Table 135. SAMEA Biologics Development Service Revenue by Application (2021-2026) & (US$ Million) Table 136. SAMEA Biologics Development Service Revenue by Application (2027-2032) & (US$ Million) Table 137. SAMEA Biologics Development Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. SAMEA Biologics Development Service Revenue by Country (2021-2026) & (US$ Million) Table 139. SAMEA Biologics Development Service Revenue by Country (US$ Million) & (2027-2032) Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Biologics Development Service Image Figure 2. Global Biologics Development Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biologics Development Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Vaccine Image Figure 5. Blood and Blood Components Image Figure 6. Tissue and Recombinant Therapeutic Proteins Image Figure 7. Others Image Figure 8. Global Biologics Development Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Biologics Development Service Market Size Share 2021 VS 2025 VS 2032 Figure 10. Tumor Treatment Image Figure 11. Chronic Disease Treatment Image Figure 12. Enzyme and Hormone Deficiencies Image Figure 13. Others Image Figure 14. Global Biologics Development Service Market Size (US$ Million) & (2021-2032) Figure 15. Global Biologics Development Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Biologics Development Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Biologics Development Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Biologics Development Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Biologics Development Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Biologics Development Service Revenue Market Share by Type (2021-2032) Figure 22. Global Biologics Development Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Biologics Development Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Biologics Development Service Revenue Market Share by Application (2021-2032) Figure 25. North America Biologics Development Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Biologics Development Service Revenue Share by Type (2021-2032) Figure 27. North America Biologics Development Service Revenue Share by Application (2021-2032) Figure 28. North America Biologics Development Service Revenue Share by Country (2021-2032) Figure 29. United States Biologics Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Biologics Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Biologics Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Biologics Development Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Biologics Development Service Revenue Share by Type (2021-2032) Figure 34. Europe Biologics Development Service Revenue Share by Application (2021-2032) Figure 35. Europe Biologics Development Service Revenue Share by Country (2021-2032) Figure 36. Germany Biologics Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Biologics Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Biologics Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Biologics Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Biologics Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Biologics Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Biologics Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Biologics Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Biologics Development Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Biologics Development Service Revenue Share by Type (2021-2032) Figure 46. China Biologics Development Service Revenue Share by Application (2021-2032) Figure 47. Asia Biologics Development Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Biologics Development Service Revenue Share by Type (2021-2032) Figure 49. Asia Biologics Development Service Revenue Share by Application (2021-2032) Figure 50. Asia Biologics Development Service Revenue Share by Region (2021-2032) Figure 51. Japan Biologics Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Biologics Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Biologics Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Biologics Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Biologics Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Biologics Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Biologics Development Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Biologics Development Service Revenue Share by Type (2021-2032) Figure 59. SAMEA Biologics Development Service Revenue Share by Application (2021-2032) Figure 60. SAMEA Biologics Development Service Revenue Share by Country (2021-2032) Figure 61. Brazil Biologics Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Biologics Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Biologics Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Biologics Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Biologics Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Biologics Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Biologics Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Biologics Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Biologics Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Biologics Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Biologics Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Vaccine
  • Blood and Blood Components
  • Tissue and Recombinant Therapeutic Proteins
  • Others
Applications
  • Tumor Treatment
  • Chronic Disease Treatment
  • Enzyme and Hormone Deficiencies
  • Others
Companies covered
  • Meso Scale Discovery
  • Patheon
  • Immunologix
  • GenScript
  • Promega
  • Recibiopharm
  • Alcami Biologics
  • Leadgene Biomedical
  • Samsung Biologics
  • Lonza
  • ImmunoGen
  • Seattle Genetics
  • Roche
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Biologics Development Service Market by Type
  3. 1.2.1 Global Biologics Development Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Vaccine
  5. 1.2.3 Blood and Blood Components
  6. 1.2.4 Tissue and Recombinant Therapeutic Proteins
  7. 1.2.5 Others
  8. 1.3 Biologics Development Service Market by Application
  9. 1.3.1 Global Biologics Development Service Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Tumor Treatment
  11. 1.3.3 Chronic Disease Treatment
  12. 1.3.4 Enzyme and Hormone Deficiencies
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Biologics Development Service Market Dynamics
  1. 2.1 Biologics Development Service Industry Trends
  2. 2.2 Biologics Development Service Industry Drivers
  3. 2.3 Biologics Development Service Industry Opportunities and Challenges
  4. 2.4 Biologics Development Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Biologics Development Service Market Perspective (2021-2032)
  2. 3.2 Global Biologics Development Service Growth Trends by Region
  3. 3.2.1 Global Biologics Development Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Biologics Development Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Biologics Development Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Biologics Development Service Revenue by Players
  2. 4.1.1 Global Biologics Development Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Biologics Development Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Biologics Development Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Biologics Development Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Biologics Development Service Key Players Headquarters & Area Served
  7. 4.4 Global Biologics Development Service Players, Product Type & Application
  8. 4.5 Global Biologics Development Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Biologics Development Service Market CR5 and HHI
  11. 4.6.3 2025 Biologics Development Service Tier 1, Tier 2, and Tier 3
5 Biologics Development Service Market Size by Type
  1. 5.1 Global Biologics Development Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Biologics Development Service Revenue by Type (2021-2032)
  3. 5.3 Global Biologics Development Service Revenue Market Share by Type (2021-2032)
6 Biologics Development Service Market Size by Application
  1. 6.1 Global Biologics Development Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Biologics Development Service Revenue by Application (2021-2032)
  3. 6.3 Global Biologics Development Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Meso Scale Discovery
  2. 7.1.1 Meso Scale Discovery Company Information
  3. 7.1.2 Meso Scale Discovery Business Overview
  4. 7.1.3 Meso Scale Discovery Biologics Development Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Meso Scale Discovery Biologics Development Service Product Portfolio
  6. 7.1.5 Meso Scale Discovery Recent Developments
  7. 7.2 Patheon
  8. 7.2.1 Patheon Company Information
  9. 7.2.2 Patheon Business Overview
  10. 7.2.3 Patheon Biologics Development Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Patheon Biologics Development Service Product Portfolio
  12. 7.2.5 Patheon Recent Developments
  13. 7.3 Immunologix
  14. 7.3.1 Immunologix Company Information
  15. 7.3.2 Immunologix Business Overview
  16. 7.3.3 Immunologix Biologics Development Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Immunologix Biologics Development Service Product Portfolio
  18. 7.3.5 Immunologix Recent Developments
  19. 7.4 GenScript
  20. 7.4.1 GenScript Company Information
  21. 7.4.2 GenScript Business Overview
  22. 7.4.3 GenScript Biologics Development Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 GenScript Biologics Development Service Product Portfolio
  24. 7.4.5 GenScript Recent Developments
  25. 7.5 Promega
  26. 7.5.1 Promega Company Information
  27. 7.5.2 Promega Business Overview
  28. 7.5.3 Promega Biologics Development Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Promega Biologics Development Service Product Portfolio
  30. 7.5.5 Promega Recent Developments
  31. 7.6 Recibiopharm
  32. 7.6.1 Recibiopharm Company Information
  33. 7.6.2 Recibiopharm Business Overview
  34. 7.6.3 Recibiopharm Biologics Development Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Recibiopharm Biologics Development Service Product Portfolio
  36. 7.6.5 Recibiopharm Recent Developments
  37. 7.7 Alcami Biologics
  38. 7.7.1 Alcami Biologics Company Information
  39. 7.7.2 Alcami Biologics Business Overview
  40. 7.7.3 Alcami Biologics Biologics Development Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Alcami Biologics Biologics Development Service Product Portfolio
  42. 7.7.5 Alcami Biologics Recent Developments
  43. 7.8 Leadgene Biomedical
  44. 7.8.1 Leadgene Biomedical Company Information
  45. 7.8.2 Leadgene Biomedical Business Overview
  46. 7.8.3 Leadgene Biomedical Biologics Development Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Leadgene Biomedical Biologics Development Service Product Portfolio
  48. 7.8.5 Leadgene Biomedical Recent Developments
  49. 7.9 Samsung Biologics
  50. 7.9.1 Samsung Biologics Company Information
  51. 7.9.2 Samsung Biologics Business Overview
  52. 7.9.3 Samsung Biologics Biologics Development Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Samsung Biologics Biologics Development Service Product Portfolio
  54. 7.9.5 Samsung Biologics Recent Developments
  55. 7.10 Lonza
  56. 7.10.1 Lonza Company Information
  57. 7.10.2 Lonza Business Overview
  58. 7.10.3 Lonza Biologics Development Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Lonza Biologics Development Service Product Portfolio
  60. 7.10.5 Lonza Recent Developments
  61. 7.11 ImmunoGen
  62. 7.11.1 ImmunoGen Company Information
  63. 7.11.2 ImmunoGen Business Overview
  64. 7.11.3 ImmunoGen Biologics Development Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 ImmunoGen Biologics Development Service Product Portfolio
  66. 7.11.5 ImmunoGen Recent Developments
  67. 7.12 Seattle Genetics
  68. 7.12.1 Seattle Genetics Company Information
  69. 7.12.2 Seattle Genetics Business Overview
  70. 7.12.3 Seattle Genetics Biologics Development Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Seattle Genetics Biologics Development Service Product Portfolio
  72. 7.12.5 Seattle Genetics Recent Developments
  73. 7.13 Roche
  74. 7.13.1 Roche Company Information
  75. 7.13.2 Roche Business Overview
  76. 7.13.3 Roche Biologics Development Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Roche Biologics Development Service Product Portfolio
  78. 7.13.5 Roche Recent Developments
  79. 7.14 Takeda
  80. 7.14.1 Takeda Company Information
  81. 7.14.2 Takeda Business Overview
  82. 7.14.3 Takeda Biologics Development Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Takeda Biologics Development Service Product Portfolio
  84. 7.14.5 Takeda Recent Developments
8 North America
  1. 8.1 North America Biologics Development Service Revenue (2021-2032)
  2. 8.2 North America Biologics Development Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Biologics Development Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Biologics Development Service Revenue by Type (2027-2032)
  5. 8.3 North America Biologics Development Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Biologics Development Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Biologics Development Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Biologics Development Service Revenue by Application (2027-2032)
  9. 8.5 North America Biologics Development Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Biologics Development Service Revenue by Country
  11. 8.6.1 North America Biologics Development Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Biologics Development Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Biologics Development Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Biologics Development Service Revenue (2021-2032)
  2. 9.2 Europe Biologics Development Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Biologics Development Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Biologics Development Service Revenue by Type (2027-2032)
  5. 9.3 Europe Biologics Development Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Biologics Development Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Biologics Development Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Biologics Development Service Revenue by Application (2027-2032)
  9. 9.5 Europe Biologics Development Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Biologics Development Service Revenue by Country
  11. 9.6.1 Europe Biologics Development Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Biologics Development Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Biologics Development Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Biologics Development Service Revenue (2021-2032)
  2. 10.2 China Biologics Development Service Revenue by Type (2021-2032)
  3. 10.2.1 China Biologics Development Service Revenue by Type (2021-2026)
  4. 10.2.2 China Biologics Development Service Revenue by Type (2027-2032)
  5. 10.3 China Biologics Development Service Revenue Share by Type (2021-2032)
  6. 10.4 China Biologics Development Service Revenue by Application (2021-2032)
  7. 10.4.1 China Biologics Development Service Revenue by Application (2021-2026)
  8. 10.4.2 China Biologics Development Service Revenue by Application (2027-2032)
  9. 10.5 China Biologics Development Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Biologics Development Service Revenue (2021-2032)
  2. 11.2 Asia Biologics Development Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Biologics Development Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Biologics Development Service Revenue by Type (2027-2032)
  5. 11.3 Asia Biologics Development Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Biologics Development Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Biologics Development Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Biologics Development Service Revenue by Application (2027-2032)
  9. 11.5 Asia Biologics Development Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Biologics Development Service Revenue by Country
  11. 11.6.1 Asia Biologics Development Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Biologics Development Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Biologics Development Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Biologics Development Service Revenue (2021-2032)
  2. 12.2 SAMEA Biologics Development Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Biologics Development Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Biologics Development Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Biologics Development Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Biologics Development Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Biologics Development Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Biologics Development Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Biologics Development Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Biologics Development Service Revenue by Country
  11. 12.6.1 SAMEA Biologics Development Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Biologics Development Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Biologics Development Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst